RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study. En savoir plus sur RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. En savoir plus sur Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.